Vinco Ventures, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2021

The disaggregated Company’s revenues for the three months ended March 31, 2021 and 2020 was as follows:

	For the Three Months Ended March 31,
	2021		2020

Revenues:
Product sales	$	2,487,869	$	3,626,901
Licensing revenues		77,293		40,209
Total revenues, net	$	2,565,162	$	3,667,110

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas

For the three months ended March 31, 2021 and 2020, the following customer represented more than 10% of total net revenues:

	For the Three Months Ended March 31,
	2021			2020
Customer A		14	%		11	%

* Customer did not represent greater than 10% of total net revenue.

For the three months ended March 31, 2021 and 2020, the following geographical regions represented more than 10% of total net revenues:

	For the Three Months Ended March 31,
	2021			2020
North America		100	%		82	%
Europe		*	%		17	%

* Region did not represent greater than 10% of total net revenue.

Schedule of Fair Value Financial Assets and Liabilities

The following fair value of financial assets and liabilities and the input level used to determine the fair value at March 31, 2021 is presented below:

	Fair Value Measurements as of March 31, 2021
	Level 1		Level 2		Level 3

Assets:
Short-term investments	$	948,000	$	-	$	-

Liabilities:
Warrant liability		-		-		58,235,566
Total		948,000		-		58,235,566

Schedule of Reconciliation of Liabilities Measured at Fair Value

The following table presents a reconciliation of the Company’s liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2021:

	Warrant Liability (Level 3)
Balance, December 31, 2020	$	-
Issuance of warrants		94,876,535
Change in fair value		(36,381,542	)
Exercise of warrants		(259,427	)
Balance, March 31, 2021	$	58,235,566

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

As of March 31, 2021 and 2020, the Company excluded the common stock equivalents summarized below, which entitled the holders thereof to ultimately acquire shares of common stock, from its calculation of earnings per share, as their effect would have been anti-dilutive.

	March 31,		March 31,
	2021		2020
Selling Agent Warrants		-		160,492
Placement Agent Warrants		2,034,346		-
Options		80,000		80,000
Convertible shares under notes payable		2,647,587		285,632
Warrants		35,068,188		-
Series B Convertible Stock		764,618		-
Shares to be issued		1,608,355		-
Total	$	42,203,094	$	526,124